Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie — Clinical Trial Site

11 Registered trials

6 Currently recruiting

Organisation

Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie

Location

Lublin, Poland

Identifier

ORG-100044903

Address

Aleja Krasnicka 100, 20-718, Poland

Departments

Cardiology
Department of Cardiology and Intensive Care Unit
Oddz. Kardiologii Pododdz. Intensywnego Nadzoru Kardiologicznego Pododdz. Rehabilitacji Kardiolog.
Oddział Kardiolog.-Pododdział Intens. Nadz. Kardiolog.-Pododdział Rehab. Kardiolog.
Oddział Kardiologii
Oddział Kardiologii - Pododdział Intensywnego Nadzoru Kardiologicznego-Pododdział Rehabilitacji Kar.
Oddział Kardiologii – Pododdział Intensywnego Nadzoru Kardiologicznego – Pododdział Reh. Kardiol.
Oddział Kardiologii, Pododdział Intensywnego Nadzoru Kardiologicznego, Pododdział Rehabilitacji Kard
Oddział Nefrologii i Nadciśnienia Tętniczego
Oncology Clinic
Oncology Department

Clinical trials at this site (11)

Search interface

A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with In… Pending

2025-521769-29-00 Pulmonary Hypertension Associated with Interstitial Lun 5
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Pulmonary Hypertension associated with interstitial lun 5 2026-04-21
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting

2024-513613-12-00 Part A: Healthy volunteers (Part A is not applicable to 9 2025-09-18
BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Idiopathic steroid-sensitive nephrotic syndrome 5 2025-04-28
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent … Recruiting

2023-506791-27-00 pulmonary arterial hypertension 5 2022-04-22
A clinical study of sotatercept in people with pulmonary hypertension (MK-7962-023) Ended

2024-515773-99-00 Pulmonary Hypertension 4 2025-05-26
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure Ended

2024-518685-27-00 acute/decompensated heart failure 5 2022-03-22
A Phase 2 Study of Sotatercept for Combined Postcapillary and Precapillary Pulmonary Hypertension Treatment Ended

2023-509141-12-00 Combined Postcapillary and Precapillary Pulmonary Hyper 4 2022-04-28